PNAS:持续感染如何为机体提供长期免疫保护?新研究揭示其中原因

2017-01-20 佚名 生物谷

许多感染性疾病都是发生一次之后,病人就会对相同疾病获得免疫。对于其中一些感染来说——以水痘为例——会有一小部分微生物在症状消退之后仍然残存于体内,当人的免疫力因年龄或疾病发生下降,这些微生物会重新活跃起来并引起疾病再次发生。来自华盛顿大学医学院的研究人员通过对利什曼病进行研究,为长期感染与长期免疫之间存在的看似矛盾的联系找到了一个解释。这种热带疾病每年杀死数万人。通过持续提醒免疫系统引起利


许多感染性疾病都是发生一次之后,病人就会对相同疾病获得免疫。对于其中一些感染来说——以水痘为例——会有一小部分微生物在症状消退之后仍然残存于体内,当人的免疫力因年龄或疾病发生下降,这些微生物会重新活跃起来并引起疾病再次发生。

来自华盛顿大学医学院的研究人员通过对利什曼病进行研究,为长期感染与长期免疫之间存在的看似矛盾的联系找到了一个解释。这种热带疾病每年杀死数万人。通过持续提醒免疫系统引起利什曼病的寄生虫长什么样子,持续感染能够让免疫系统保持警觉,对抗新的入侵者。

相关研究结果发表在国际学术期刊PNAS上。

“许多病原体会引起持续感染,但是其中的过程仍然是一个黑匣子。没人知道在持续感染过程中到底发生了什么,为何会与免疫有关。”该研究第一作者Michael Mandell这样说道。

普遍认为病人从利什曼病中恢复以后体内仍残存寄生虫,寄生虫的持续存在可能对于人类宿主来说有一定好处。对小鼠进行的研究曾表明完全清除寄生虫常会导致动物容易受到再次感染。

研究发现大多数寄生虫居住在能够杀死它们的免疫细胞中,尽管居住的环境很危险但是这些寄生虫的形状和尺寸仍然看起来很正常。除此之外寄生虫还会进行扩增,而寄生虫的总数会维持在一个稳定的水平。

寄居着寄生虫的免疫细胞主要负责杀死病原体,激活更强的免疫应答。研究人员认为正是寄生虫持续扩增以及被免疫细胞杀伤的过程导致了与持续感染相关的长期免疫,这也解释了为何病人再次碰到相同病原体不会出现疾病症状。

“看起来我们的免疫记忆有时也需要得到提醒。随着病原体的持续扩增和被杀伤,它们能够不断刺激免疫系统,让免疫系统时刻准备应对寄生虫造成的再次感染。”Mandell这样说道。

这些发现表明持续感染除了会造成一些危险,也会带来一些好处。想要开发可以诱发长期免疫的疫苗可能需要既能持续存在又不会使人致病的活疫苗。

原始出处 

Michael A. Mandella,1 and Stephen M. Beverleya,2.Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts.PNAS.2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2025379, encodeId=71a420253e9a4, content=<a href='/topic/show?id=1c0f28959c4' target=_blank style='color:#2F92EE;'>#免疫保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28959, encryptionId=1c0f28959c4, topicName=免疫保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Fri Oct 13 17:45:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855952, encodeId=584018559524d, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Mon Jul 03 18:45:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171746, encodeId=c9621e174607, content=谢谢,学习知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Jan 21 09:22:06 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171575, encodeId=10ed1e1575ca, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Jan 20 11:33:50 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171560, encodeId=9a281e156057, content=感染不是坏事,提高机体抵抗力。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01bb1684217, createdName=医张生, createdTime=Fri Jan 20 10:43:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171559, encodeId=791e1e1559b3, content=不错的研究,, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLANdGNYWvk9OTHBSjRCzaGx04BNarqydV8842u14zqzKAwdlCIR1FFkX9F009HlTrADV6uUOiabReA/0, createdBy=ebc61983133, createdName=1e1896dfm83(暂无匿称), createdTime=Fri Jan 20 10:40:09 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171557, encodeId=f5321e1557bb, content=什么时候可以获得长期免疫, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Fri Jan 20 10:31:11 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2025379, encodeId=71a420253e9a4, content=<a href='/topic/show?id=1c0f28959c4' target=_blank style='color:#2F92EE;'>#免疫保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28959, encryptionId=1c0f28959c4, topicName=免疫保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Fri Oct 13 17:45:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855952, encodeId=584018559524d, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Mon Jul 03 18:45:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171746, encodeId=c9621e174607, content=谢谢,学习知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Jan 21 09:22:06 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171575, encodeId=10ed1e1575ca, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Jan 20 11:33:50 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171560, encodeId=9a281e156057, content=感染不是坏事,提高机体抵抗力。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01bb1684217, createdName=医张生, createdTime=Fri Jan 20 10:43:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171559, encodeId=791e1e1559b3, content=不错的研究,, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLANdGNYWvk9OTHBSjRCzaGx04BNarqydV8842u14zqzKAwdlCIR1FFkX9F009HlTrADV6uUOiabReA/0, createdBy=ebc61983133, createdName=1e1896dfm83(暂无匿称), createdTime=Fri Jan 20 10:40:09 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171557, encodeId=f5321e1557bb, content=什么时候可以获得长期免疫, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Fri Jan 20 10:31:11 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-07-03 drwjr
  3. [GetPortalCommentsPageByObjectIdResponse(id=2025379, encodeId=71a420253e9a4, content=<a href='/topic/show?id=1c0f28959c4' target=_blank style='color:#2F92EE;'>#免疫保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28959, encryptionId=1c0f28959c4, topicName=免疫保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Fri Oct 13 17:45:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855952, encodeId=584018559524d, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Mon Jul 03 18:45:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171746, encodeId=c9621e174607, content=谢谢,学习知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Jan 21 09:22:06 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171575, encodeId=10ed1e1575ca, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Jan 20 11:33:50 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171560, encodeId=9a281e156057, content=感染不是坏事,提高机体抵抗力。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01bb1684217, createdName=医张生, createdTime=Fri Jan 20 10:43:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171559, encodeId=791e1e1559b3, content=不错的研究,, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLANdGNYWvk9OTHBSjRCzaGx04BNarqydV8842u14zqzKAwdlCIR1FFkX9F009HlTrADV6uUOiabReA/0, createdBy=ebc61983133, createdName=1e1896dfm83(暂无匿称), createdTime=Fri Jan 20 10:40:09 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171557, encodeId=f5321e1557bb, content=什么时候可以获得长期免疫, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Fri Jan 20 10:31:11 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-01-21 flysky120

    谢谢,学习知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2025379, encodeId=71a420253e9a4, content=<a href='/topic/show?id=1c0f28959c4' target=_blank style='color:#2F92EE;'>#免疫保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28959, encryptionId=1c0f28959c4, topicName=免疫保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Fri Oct 13 17:45:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855952, encodeId=584018559524d, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Mon Jul 03 18:45:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171746, encodeId=c9621e174607, content=谢谢,学习知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Jan 21 09:22:06 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171575, encodeId=10ed1e1575ca, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Jan 20 11:33:50 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171560, encodeId=9a281e156057, content=感染不是坏事,提高机体抵抗力。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01bb1684217, createdName=医张生, createdTime=Fri Jan 20 10:43:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171559, encodeId=791e1e1559b3, content=不错的研究,, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLANdGNYWvk9OTHBSjRCzaGx04BNarqydV8842u14zqzKAwdlCIR1FFkX9F009HlTrADV6uUOiabReA/0, createdBy=ebc61983133, createdName=1e1896dfm83(暂无匿称), createdTime=Fri Jan 20 10:40:09 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171557, encodeId=f5321e1557bb, content=什么时候可以获得长期免疫, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Fri Jan 20 10:31:11 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-01-20 忠诚向上

    好好学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2025379, encodeId=71a420253e9a4, content=<a href='/topic/show?id=1c0f28959c4' target=_blank style='color:#2F92EE;'>#免疫保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28959, encryptionId=1c0f28959c4, topicName=免疫保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Fri Oct 13 17:45:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855952, encodeId=584018559524d, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Mon Jul 03 18:45:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171746, encodeId=c9621e174607, content=谢谢,学习知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Jan 21 09:22:06 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171575, encodeId=10ed1e1575ca, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Jan 20 11:33:50 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171560, encodeId=9a281e156057, content=感染不是坏事,提高机体抵抗力。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01bb1684217, createdName=医张生, createdTime=Fri Jan 20 10:43:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171559, encodeId=791e1e1559b3, content=不错的研究,, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLANdGNYWvk9OTHBSjRCzaGx04BNarqydV8842u14zqzKAwdlCIR1FFkX9F009HlTrADV6uUOiabReA/0, createdBy=ebc61983133, createdName=1e1896dfm83(暂无匿称), createdTime=Fri Jan 20 10:40:09 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171557, encodeId=f5321e1557bb, content=什么时候可以获得长期免疫, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Fri Jan 20 10:31:11 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-01-20 医张生

    感染不是坏事,提高机体抵抗力。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2025379, encodeId=71a420253e9a4, content=<a href='/topic/show?id=1c0f28959c4' target=_blank style='color:#2F92EE;'>#免疫保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28959, encryptionId=1c0f28959c4, topicName=免疫保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Fri Oct 13 17:45:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855952, encodeId=584018559524d, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Mon Jul 03 18:45:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171746, encodeId=c9621e174607, content=谢谢,学习知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Jan 21 09:22:06 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171575, encodeId=10ed1e1575ca, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Jan 20 11:33:50 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171560, encodeId=9a281e156057, content=感染不是坏事,提高机体抵抗力。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01bb1684217, createdName=医张生, createdTime=Fri Jan 20 10:43:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171559, encodeId=791e1e1559b3, content=不错的研究,, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLANdGNYWvk9OTHBSjRCzaGx04BNarqydV8842u14zqzKAwdlCIR1FFkX9F009HlTrADV6uUOiabReA/0, createdBy=ebc61983133, createdName=1e1896dfm83(暂无匿称), createdTime=Fri Jan 20 10:40:09 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171557, encodeId=f5321e1557bb, content=什么时候可以获得长期免疫, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Fri Jan 20 10:31:11 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-01-20 1e1896dfm83(暂无匿称)

    不错的研究,

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2025379, encodeId=71a420253e9a4, content=<a href='/topic/show?id=1c0f28959c4' target=_blank style='color:#2F92EE;'>#免疫保护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28959, encryptionId=1c0f28959c4, topicName=免疫保护)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Fri Oct 13 17:45:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855952, encodeId=584018559524d, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Mon Jul 03 18:45:00 CST 2017, time=2017-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171746, encodeId=c9621e174607, content=谢谢,学习知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Jan 21 09:22:06 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171575, encodeId=10ed1e1575ca, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Jan 20 11:33:50 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171560, encodeId=9a281e156057, content=感染不是坏事,提高机体抵抗力。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01bb1684217, createdName=医张生, createdTime=Fri Jan 20 10:43:15 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171559, encodeId=791e1e1559b3, content=不错的研究,, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLANdGNYWvk9OTHBSjRCzaGx04BNarqydV8842u14zqzKAwdlCIR1FFkX9F009HlTrADV6uUOiabReA/0, createdBy=ebc61983133, createdName=1e1896dfm83(暂无匿称), createdTime=Fri Jan 20 10:40:09 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171557, encodeId=f5321e1557bb, content=什么时候可以获得长期免疫, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Fri Jan 20 10:31:11 CST 2017, time=2017-01-20, status=1, ipAttribution=)]
    2017-01-20 ren1mw

    什么时候可以获得长期免疫

    0

相关资讯

CELL RES:癌症免疫治疗及精准医学进展

利用免疫系统来根除肿瘤细胞正在成为一种最有力的新型癌症治疗方法。那么目前关于这一热点话题的研究进展如何呢?近期一项发表在CELL RES杂志上的文章综述了癌症免疫治疗的最新进展以及新的战略在鉴定新的免疫靶点和突变衍生抗原(新抗原)对癌症免疫治疗和免疫精准医学的进展。FDA批准基于免疫治疗的药物sipuleucel-T(Provenge)、ipilimumab(抗CTLA-4)以及最近研究火热的程序

Nat Immunol:为什么女性更容易关节疼?

自身免疫性疾病是指机体对自身抗原发生免疫反应而导致自身组织损害所引起的疾病,有多种类型,例如过敏性皮炎、关节炎、肾炎、红斑狼疮等等。但是,所有的疾病都更倾向于在女性身上发生,其中80%的患者都是女性。为什么这一疾病会存在性别差异呢?        近期,来自于密歇根大学的科学家们找到了一个基因“总开关”——VGLL3。

JIM:俄科学家用基因剪刀找到抵御白血病病毒抗体

有研究发现,人体内本该攻击某些病毒的T细胞表面存在能给病毒“带路”并引发感染的受体。为堵住这一“内应通道”,俄罗斯研究人员利用CRISPR-Cas9“基因剪刀”技术,为T细胞找到了抵御某种特定逆转录病毒的新抗体。这种方法或有助于治疗白血病、艾滋病相关药物的研发。 人类T细胞白血病病毒Ⅰ型(HTLV-1病毒)是一种逆转录病毒,能引发白血病,且与数种恶性肿瘤发病相关。这种病毒可攻入人体免疫细

曹雪涛院士、陈涛涌教授《Science》子刊发表免疫学研究成果

导读:来自第二军医大学和中国医学科学院的研究人员证实,在病毒感染后,酪氨酸激酶Src可促进激酶TBK1的磷酸化,以帮助I型干扰素的产生。相关研究结果发表在1月3日的Science子刊《Science Signaling》。我国著名的免疫学家曹雪涛(Xuetao Cao)院士及第二军医大学的陈涛涌(Taoyong Chen)教授是这篇论文的共同通讯作者。

美国和日本免疫学家获颁“复旦-中植科学奖”

第二届“复旦科技创新论坛”举行